Rhythm Pharmaceuticals, Inc. Insider Trading Activity
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Insider Trade Summary
Grant/Award: 11,749 shares
Grant/Award
2 txns
Insider
Bedrosian Camille L
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 7,037 | $0.00 | $0.00 |
| Grant/Award | Restricted Stock Units | 4,712 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 7,037 options (Direct);
Restricted Stock Units — 4,712 units (Direct)
Footnotes (3)
- F1. The options fully vest upon the earlier of (i) June 24, 2026 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2026, subject to the Reporting Person's continued service on such vesting date.
- F2. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- F3. The restricted stock units fully vest upon the earlier of (i) June 24, 2026 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2026, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date.
AI-generated analysis. How Rhea-AI works. Not financial advice.